RHO and colorectal carcinoma: Further, inhibitors upstream of RAF, such as the RAS inhibitor salisarib, RAS/RHO inhibitor zoledronic acid, or EGFR inhibitor gefitinib did not induce SPINK1 secretion in BRAF V600E CRC cells.